Who We Are
Investor Relations

Global pharma achieves future readiness through an active 3-year pharmacovigilance transformation roadmap

The Customer

A leading mid sized European pharmaceutical company, with interests across multiple therapeutic areas.

The Need

With impending multiple drug launches over the next few years, the new leadership helming PV wanted to create a business case for a 3-year transformation roadmap for future readiness to

Understand current industry trends and competitive position

Learn about Latest innovations and technology solutions in PV

Create a Blueprint for the vision of a lean PV function that is at par with industry’s best-in-class

Business case was to be created keeping in mind the organization’s current systems and processes and taking a practical approach with incremental change

The Solution

Indegene carried out an in-depth study of the client's processes and systems

Internal and market leaders were interviewed to benchmark the current maturity state as compared to the industry

Industry solutions and best practices were contextualized to client needs

A transformation roadmap was prepared along with an investment case and 'to-be' business, process, and system architecture

Detailed execution plan with specific stakeholder ownership put into action multiple initiatives along with identified third-party partnerships


We established a programmatic evaluation process for the changing competitive landscape. The client was able to achieve consensus and confidence amongst internal stakeholders, on the launch plan. The product launch plan was used to target the competitive environment differently.